Banner overlay
Back to Product Catalog

AprèsFlex®

Trusted Joint Relief – in Only 5 Days.
 
Request More Info Get a Sample
Benifit Image
5 Days
AprèsFlex has been shown in clinical trials to improve joint comfort in as little as 5 days.
Benifit Image
100 mg
Proven efficacy at only 100 mg/day.
Benifit Image
10 Studies
The science behind AprèsFlex is solid. It is supported by 7 pre-clinical and 3 human clinical trials.

Flexibility is Freedom

When we play a round of golf or spend an afternoon on our knees in the garden or just take a nice long walk, we are celebrating our freedom.

AprèsFlex has been giving people back their freedom for almost a decade, by delivering joint comfort and flexibility from 100 mg dose that starts to work in only 5 days.

Around the world, people have turned to AprèsFlex more than a billion times as a drug-free approach to joint comfort. They trust the science. Trust the quality. And trust the experience.

Key Features

  • Low dose (100 mg/d) solution for joint health
  • AprèsFlex® supports healthy joints and connective tissues
  • Clinically-studied using validated tests of function and blood markers
  • Helps improve bioavailability and bioactivity of AKBA
  • A previously unrecognized synergistic benefit of Boswellia extracts
  • Demonstrates significant 5-Lipoxygenase inhibition
  • Superior MMP-3 inhibition
Boswellia02
Good For
Ingredient Solutions
Healthy Aging
Bone, Joint & Muscle
Applications
Capsules
Tablets
Effervescents
Powders
Stick Packs
Soft Gels

Certifications

Clinical Science
Clinical Science
Patented
Patented
Kosher
Kosher
Halal
Halal
Non-GMO
Non-GMO
Gluten-Free
Gluten-Free
gettyimages-635800174-170667a

Active/Sports Nutrition

AprèsFlex can be an important part of your active/sports nutrition formulations. Inflammation from exercise has similarities to the type of inflammation that occurs with the aging process. AprèsFlex can help you get your customers back into the gym faster – and happier.

Bone, Joint & Muscle Health

AprèsFlex is one of the world’s best-selling joint health ingredients – with multiple clinical studies that demonstrate efficacy starting at 5 days – with a low dose. Clinical studies have shown a 20% reduction in pain scores at 5 days and p to a 70% reduction in 90 days.

Warming up outdoors in the fall. Quadriceps standing
Jogging, Senior Adult, Running, Senior Couple, Sport

Healthy Aging

Today’s seniors travel more, play more and do more than ever. AprèsFlex can help them get moving and keep moving. They’ll notice the difference quickly and come back for more.

Weight Management

Mobility and freedom from discomfort are critical to the kind of exercise we need to maintain a healthy weight. AprèsFlex can help your customers succeed in achieving their weight management goals by giving them the freedom to workout.

Female leg stepping on weigh scales. Healthy lifestyle, food and sport concept.
Research

Enhanced Joint Comfort They Can Count On

Clinical studies conducted with AprèsFlex show dramatic improvements in joint comfort. A 2014 clinical trial with AprèsFlex showed a nearly 20% reduction in pain scores over baseline at 5 days and a 50% reduction in pain scores at 30 days. A previous, similar study with AprèsFlex showed a 70% reduction in pain scores at 90 days.

Beyond joint comfort and flexibility improvements, AprèsFlex also positively impacts biological markers associated with joint health and inflammation, including TNFa, CRP, and IL-6. It was also shown to significantly inhibit matrix metalloproteinase (MMP-3), enzymes that break down cartilage, collagen and connective tissues.

For Joint Health

AprèsFlex shows BETTER and FASTER efficacy
  • Initial clinical work compared efficacy between existing (5-LOXIN) and new (AprèsFlex) Boswellia ingredients.
  • AprèsFlex (100 mg/d) shows quicker efficacy in WOMAC pain and Stiffness scores
apresflex graph1

AprèsFlex® 5-day Efficacy

  • AprèsFlex® (100 mg/d) shows significant improvement vs. placebo in VAS (pain) and LFI (function) scores beginning as early as 5 days.
apresflex graph2
INSIGHTS

Derived from Boswellia Serrata Gum Resin

AprèsFlex is derived from Boswellia serrata gum resin and contains 20% AKBA. It was developed based upon a 1st generation clinically studied Boswellia serrata extract that provided 30% Acetyl-11-keto-β-boswellic acid (AKBA) along with other boswellic acids The bioavailability of AKBA from AprèsFlex was found to be significantly higher in comparison with that of other commercially available Boswellia extracts.

The starting point for AprèsFlex – Boswellia serrata – is a plant that produces Indian frankincense. It is also known as Indian oli-banum, Salai guggul, and Sallaki in Sanskrit. The plant is native to much of India and the Punjab region that extends into Pakistan. In partnership with Laila, PLT is committed to the safety and fair treatment of the people who harvest AprèsFlex. We want to support the long-term health and well-being of the tribal culture and the natural environment upon which it relies.

Quality

Every batch of the AprèsFlex harvest is assigned a specific batch number and each batch of finished product is traceable to a specific region and set of trees. AprèsFlex is tested and must comply with predefined specifications for different parameters at different stages of product manufacturing – from raw materials to finished product. Quality is monitored by a multi-disciplinary organization with dedicated departments for taxonomy (botanical Identification), raw material analysis, chemical analysis, microbiology and more.

Resources

Deliver Enhanced Joint Comfort Your Customers Can Feel

PLT has a broad range of joint health solutions that can work in almost any type of product you’re making.

Contact Us